At a recent meeting of the Macula Society, an ophthalmologist, known for his enthusiasm about radiation treatment for choroidal melanoma, presented his most recent follow-up data. His presentation emphasized the proportion of patients retaining various levels of vision for specified intervals following treatment. At the end of the presenta
See also p 655.
tion, another ophthalmologist, renowned for his keen intellect and probing questions, noted that discussion of management options for a patient with a melanoma was difficult, because he still didn't know whether to take the eye out or leave it in. The original speaker countered quickly that this was an extremely difficult question to answer, but the iconoclast interrupted just as quickly to say that all details concerning vision-saving procedures were irrelevant until the question of survival could be answered.
The article by Augsburger and others1 in this issue of the Archives is an effort to address
Fine SL. Do I Take the Eye Out or Leave It In? Arch Ophthalmol. 1986;104(5):653–654. doi:10.1001/archopht.1986.01050170043018
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: